The Boston-based company, founded in 2016, offers an end-to-end automation platform to solve challenging pathology problems faced by the research and pharmaceutical industry. Using machine and deep learning techniques, PathAI's platform analyzes massive aggregated sets to detect cancerous cells separately, improving the accuracy of diagnosis and the efficacy of treatment for diseases like cancer. With a diverse team of passionate employees, PathAI is committed to improving patient outcomes and was recently voted one of BBJ's Best Places to Work.